EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Multizentrische Studie

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn

Derek P de Winter, Kenneth J Moise, Leona E Ling, Dick Oepkes, Eleonor Tiblad, E J T Joanne Verweij, John Smoleniec, Ulrich J Sachs, Gregor Bein, Mark D Kilby, Russell S Miller, Roland Devlieger und 13 weitere

NEJM Evidence · 27.01.2026 · 5 (2)

DOI: 10.1056/evidoa2500097 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift NEJM Evidence, erschienen am 27.01.2026. Verfasst von Derek P de Winter und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Neonatology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Erythroblastosis, Fetal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedErythroblastosis, FetalAdultFemaleHumansInfant, NewbornMalePregnancyColostrumFetal BloodImmunoglobulin GMilk, HumanReceptors, FcHistocompatibility Antigens Class I

Substanzen

Antibodies, Monoclonal, HumanizedFc receptor, neonatalImmunoglobulin GReceptors, FcHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Neonatology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.
  • Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
  • Comprehensive Fetal Care Center at Dell Children's Medical Center, Austin, TX, USA.
  • Johnson & Johnson, Spring House, PA, USA.
  • Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden.

Zitieren

APA

de Winter, D. P., Moise, K. J., Ling, L. E., Oepkes, D., Tiblad, E., Joanne Verweij, E. J. T., Smoleniec, J., Sachs, U. J., Bein, G., Kilby, M. D., Miller, R. S., Devlieger, R., Streisand, J. B., Bredius, R. G. M., Cafone, J., Lam, E., Leu, J. H., Mirza, A., Nelson, R. M., …, & Lopriore, E. (2026). Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn. NEJM Evidence, 5(2). https://doi.org/10.1056/evidoa2500097

Vancouver

de Winter DP, Moise KJ, Ling LE, Oepkes D, Tiblad E, Joanne Verweij EJT, et al. Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn. NEJM Evidence. 2026;5(2). doi:10.1056/evidoa2500097

BibTeX
@article{deWinter2026,
  author = {de Winter, Derek P and Moise, Kenneth J and Ling, Leona E and Oepkes, Dick and Tiblad, Eleonor and Joanne Verweij, E J T and Smoleniec, John and Sachs, Ulrich J and Bein, Gregor and Kilby, Mark D and Miller, Russell S and Devlieger, Roland and Streisand, James B and Bredius, Robbert G M and Cafone, Joseph and Lam, Edwin and Leu, Jocelyn H and Mirza, Arpana and Nelson, Robert M and Smith, Valerie and Schwartz, Lisa B and Tjoa, May Lee and Saeed-Khawaja, Shumyla and Komatsu, Yosuke and Lopriore, Enrico},
  title = {Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn},
  journal = {NEJM Evidence},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.1056/evidoa2500097}
}
Kostenlos starten →